Cardiovascular Bioengineering: From Disease Mechanisms to Therapeutic Strategies
This special issue belongs to the section "Regenerative Engineering".
Special Issue Information
Dear Colleagues,
Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, highlighting the urgent need for innovative strategies to better understand, model, and treat cardiovascular pathology. Recent advances in bioengineering, regenerative medicine, biomaterials science, mechanobiology, and therapeutic delivery systems have significantly expanded opportunities for cardiovascular repair, regeneration, and disease modeling. Interdisciplinary approaches integrating engineering principles with cardiovascular biology are driving the development of novel technologies for tissue remodeling, fibrosis modulation, vascular regeneration, heart valve repair, and personalized therapeutics.
This Special Issue, entitled "Cardiovascular Bioengineering: From Disease Mechanisms to Therapeutic Strategies", will bring together original research articles and reviews that explore emerging bioengineering technologies and mechanistic discoveries relevant to cardiovascular biology and disease. We welcome contributions spanning basic, translational, and preclinical research that advance our understanding of cardiovascular pathophysiology and therapeutic innovation.
Topics of interest include, but are not limited to, the following:
- Biomaterials and hydrogels for cardiovascular repair and regeneration;
- Bio-scaffolds, extracellular matrices, and engineered cardiac tissues;
- Tissue engineering approaches for cardiac, vascular, and heart valve diseases;
- Mechanobiology and mechanotransduction in cardiovascular remodeling;
- Fibrosis, extracellular matrix remodeling, and fibroblast biology;
- Heart valve biology, valvular interstitial cells, and valve tissue engineering;
- Stem cell and iPSC technologies for cardiovascular applications;
- Organoids, organ-on-a-chip systems, and microfluidic disease models;
- Biomaterial-based drug delivery and therapeutic targeting;
- Gene editing, CRISPR technologies, and non-viral/viral delivery systems;
- Exosomes and extracellular vesicle-based therapeutics;
- Cardiac regeneration and vascular remodeling;
- Bioengineering approaches for myocardial infarction, atherosclerosis, and peripheral vascular disease;
- Immunomodulation and immune–biomaterial interactions
- Computational modeling, systems biology, and AI-assisted cardiovascular bioengineering;
- Omics technologies and single-cell approaches in cardiovascular research;
- Cell–cell communication and tissue crosstalk in cardiovascular disease;
- Translational and regulatory challenges in cardiovascular bioengineering;
- Emerging therapeutic strategies for cardiovascular fibrosis and tissue remodeling.
By bringing together contributions from researchers working in cardiovascular biology, regenerative medicine, biomaterials science, mechanobiology, and biomedical engineering, this Special Issue will foster interdisciplinary collaboration and accelerate the development of innovative cardiovascular therapies and technologies with translational potential.
Dr. Emre Bektik
Dr. Kurt Pfannkuche
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular bioengineering
- cardiac regeneration
- tissue remodeling
- fibrosis
- extracellular matrix
- mechanobiology
- mechanotransduction
- biomaterials
- hydrogels
- tissue engineering
- heart valve disease
- valvular interstitial cells
- cardiac fibroblasts
- vascular regeneration
- stem cells
- iPSCs
- organoids
- organ-on-a-chip
- microfluidics
- drug delivery
- exosomes
- extracellular vesicles
- CRISPR
- gene editing
- regenerative medicine
- bio-scaffolds
- myocardial infarction
- atherosclerosis
- omics
- systems biology
- computational biology
- translational medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

